Gallbladder empyema (suppurative cholecystitis1) is an uncommon complication of cholecystitis and refers to a situation where the gallbladder lumen is filled and distended by purulent material (pus).
There is an increased incidence in those with diabetes mellitus 2 and/or advanced atherosclerotic disease 7.
While patients with a gallbladder empyema may experience symptoms similar to those with acute uncomplicated cholecystitis (fever, chills, rigors, and right upper quadrant pain), signs of sepsis may not always be present.
May show the the usual sonographic features of cholecystitis with added echogenic content within the gallbladder lumen (this feature is however not specific for an empyema). In cases of extensive calculous cholecystitis where gallstones fill the galbladder lumen it may be difficult to assess the echogenicity of bile and further cross sectional imaging may be required.
May show general imaging features of cholecystitis with added high-attenuating material (representing pus) within the distended gallbladder lumen. Again this feature is non specific and is often difficult to differentiate from sludge within the gallbladder.
MRI sometimes may be helpful in distinguishing pus from sludge by using heavily T2 weighted sequences, which may show fluid-fluid levels with dependent layering of purulent bile. On other MR sequences images, pus or purulent bile may be difficult to demonstrate 2. The purulent component is usually of lower signal on T2 weighted images 7-8.
Treatment and prognosis
Management options for suppurative cholecystitis include both emergent cholecystectomy and percutaneous catheter drainage, also termed percutaneous cholecystostomy (which can later be followed by a cholecystectomy) 1,5-6. The latter option is usually reserved those with additional co-morbidities 6. The rate of conversion of a laparoscopic cholecystectomy to an open procedure is considered greater than that with cases of uncomplicated acute cholecystitis. Gallbladder empyema is associated with a significant morbidity and mortality 9.
On imaging possible considerations include
- asymmetric GB wall thickening with ulceration and irregularity of wall
- ± no doppler flow
- diminished C+ enhancement of portions of GB wall
- ± pericholecystic collection/abscess
- luminal gas with "dirty" posterior acoustic shadowing
- ring-down artifact from gas bubbles
- champagne sign
- gallbladder distension from cholecystitis without pus
- gallbladder distension with sludge within
- hepatic abscess adjacent to or intimately close to the gallbladder
- 1. Smith EA, Dillman JR, Elsayes KM et-al. Cross-sectional imaging of acute and chronic gallbladder inflammatory disease. AJR Am J Roentgenol. 2009;192 (1): 188-96. doi:10.2214/AJR.07.3803 - Pubmed citation
- 2. Watanabe Y, Nagayama M, Okumura A et-al. MR imaging of acute biliary disorders. Radiographics. 27 (2): 477-95. doi:10.1148/rg.272055148 - Pubmed citation
- 3. Gore RM, Yaghmai V, Newmark GM et-al. Imaging benign and malignant disease of the gallbladder. Radiol. Clin. North Am. 2002;40 (6): 1307-23, vi. - Pubmed citation
- 4. Adusumilli S, Siegelman ES. MR imaging of the gallbladder. Magn Reson Imaging Clin N Am. 2002;10 (1): 165-84. - Pubmed citation
- 5. Kumar S, Sharma P, Muthu R et-al. Management of empyema of gallbladder with percutaneous cholecysto-duodenal stenting in a case of hilar cholangiocarcinoma treated with common bile duct metallic stenting. Indian J Radiol Imaging. 2011;21 (4): 298-300. doi:10.4103/0971-3026.90695 - Free text at pubmed - Pubmed citation
- 5. Gatenby P, Flook M, Spalding D et-al. Percutaneous transhepatic cholecystoduodenal stent for empyema of the gallbladder. Br J Radiol. 2009;82 (978): e108-10. doi:10.1259/bjr/23124841 - Pubmed citation
- 7. O'connor OJ, Maher MM. Imaging of cholecystitis. AJR Am J Roentgenol. 2011;196 (4): W367-74. doi:10.2214/AJR.10.4340 - Pubmed citation
- 8. Brant WE, Lange EE. Essentials of Body MRI. Oxford University Press, USA. (2012) ISBN:0199738491. Read it at Google Books - Find it at Amazon
- 9. Empyema of the gallbladder - a forgotten disease. Lancet. 1984;1 (8377): 606. Pubmed citation